Use access key #2 to skip to page content.
$2.89 0.25 (9.47%)
7/8/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
*

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

1

Avatar KatWoman50 (95.46) Submitted: 4/09/08 2:46 PM : Outperform Start Price: $2.29 MNKD Score: 20.27

60% drop on Pfizer report on inhaled insulin. Who knows... look for the bounce.

Report this Post Replies: 0 | Reply

Featured Broker Partners